# Biolargo, Inc.: Form 8-K, filed Sep 11, 2026

- Company: [Biolargo, Inc.](/companies/blgo.md) (CIK 880242)
- Form: 8-K
- Filed: 2026-09-11
- Accepted by EDGAR: Sep 11, 2026, 10:38 ET
- Period: 2026-09-10
- Accession: 0001437749-26-030124
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/880242/000143774926030124/blgo20260910_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/880242/000143774926030124/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/880242/000143774926030124/blgo20260910_8k.htm

Filed Sep 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-030124. Last ingested by Listed: Nov 2, 2026, 06:21 ET. No prices; not investment advice.